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ABSTRACT Cell-penetrating peptides (CPPs) such as HIV’s trans-activating transcriptional activator
(TAT) and polyarginine rapidly pass through the plasma membranes of mammalian cells by an unknown
mechanism called transduction. They may be medically useful when fused to well-chosen chains of
fewer than about 35 amino acids. I offer a simple model of transduction in which phosphatidylserines
and CPPs effectively form two plates of a capacitor with a voltage sufficient to cause the formation of
transient pores (electroporation). The model is consistent with experimental data on the transduction
of oligoarginine into mouse C2C12 myoblasts and makes three testable predictions.
I. CELL-PENETRATING PEPTIDES
Polyarginine, TAT [1, 2], Penetratin, and other short,
positively charged peptides can penetrate the plasma
membranes of live cells and can tow along with them
cargos that greatly exceed the 600 Da restriction bar-
rier. They are promising therapeutic tools when fused
to well-chosen sequences of fewer than about 35 amino
acids [3–15].
TAT carries cargos across cell membranes with high ef-
ficiency by at least two functionally distinct mechanisms
according to whether the cargo is big or small [16]. Big
cargos, such as proteins or quantum dots, enter via cave-
olae endocytosis and macropinocytosis [17, 18], and rel-
atively few escape the cytoplasmic vesicles in which they
then are trapped [16].
Small cargos, such as peptides of fewer than 30–40
amino acids, enter both slowly by endocytosis and rapidly
by transduction, an unknown mechanism that uses the
membrane potential [16, 19–21]. Peptides fused to TAT
enter cells within seconds [22].
Sec. II reviews some facts about plasma membranes.
Sec. III reviews how the phospholipid bilayer prevents
ions from crossing the plasma membrane. Sec. IV de-
scribes a simple model of transduction in which CPPs
on the outer leaflet and phosphatidylserines on the inner
leaflet form a kind of capacitor with a voltage sufficient
to favor the formation of transient pores (electropora-
tion). Sec. V shows that the model is consistent with
measurements made by Tu¨nnemann et al. [23] on the
transduction into mouse myoblasts of oligoarginines and
oligolysines carrying fluorophores of 400 Da. Sec. VI tells
how to test three predictions of the model. The paper
ends with a short summary in Sec.VII.
II. PLASMA MEMBRANES
The plasma membrane of a mammalian cell is a lipid
bilayer that is 4 or 5 nm thick. Of the four main phos-
pholipids in it, three—phosphatidylethanolamine (PE),
phosphatidylcholine (PC), and sphingomyelin (SM)—are
neutral, and one, phosphatidylserine (PS), is negatively
charged. In live cells, PE and PS are mostly in the cy-
tosolic layer, and PC and SM in the outer layer [24, 25].
Aminophospholipid translocase (flippase) moves PE and
PS to the inner layer; floppase slowly moves all phospho-
lipids to the outer layer [24].
Glycolipids make up about 5% of the lipid molecules
of the outer layer of a mammalian plasma membrane.
Their hydrocarbon tails normally are saturated. Instead
of a modified phosphate group, they are decorated with
galactose, glucose, GalNAc = N-acetylgalactosamine,
and other sugars. The most complex glycolipids—
the gangliosides—have negatively charged sialic-acid
(NANA) groups. Incidentally, cholera toxin binds to and
enters cells that display the GM1 ganglioside. [25]
A living cell maintains an electrostatic potential of be-
tween 20 and 120 mV across its plasma membrane. The
electric field E within the membrane points into the cell
and is huge, about 15 mV/nm or 1.5 × 107 V/m if the
potential difference is 60 mV across a membrane of 4
nm. Conventionally, one reports membrane potentials
as the electric potential inside the cell minus that out-
side, so that here ∆V = −60 mV. Near but outside
the membrane, this electric field falls-off exponentially
E(r) = E exp(−r/D`) with the ratio of the distance r
from the membrane to the Debye length D`, which is of
the order of a nanometer. The rapid entry of TAT fused
to peptides is frustrated only by agents that destroy the
electric field E [16], which applies a force qE to a CPP
of charge q.
Most of the phospholipids of the outer leaflet of the
plasma membrane are neutral PCs & SMs. They vastly
outnumber the negatively charged gangliosides, which are
a subset of the glycolipids, which themselves amount only
to 5% of the outer layer. Imagine now that CPP-cargo
molecules are in the extra-cellular environment. Many
of them will be pinned down by the electric field E(r)
just outside the membrane, their positively charged side-
chains interacting with the negative phosphate groups of
neutral dipolar PC & SM head groups. (Other CPP-
cargo molecules will stick to negatively charged gan-
gliosides and to glycosaminoglycans (GAGs) attached to
transmembrane proteoglycans (PGs); these slowly will be
endocytosed. Heparan-sulfate PGs are needed for TAT-
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protein endocytosis [26].) It is crucial that the dipolar PC
& SM head groups are neutral and so do not cancel or re-
duce the positive electric charge of a CPP-cargo molecule.
The net positive charge of a CPP-cargo molecule will at-
tract negatively charged PSs and cause them to diffuse
toward the part of the inner leaflet directly below the
CPP-cargo molecule. This is the starting point for the
model described in the next two sections.
III. THE PUZZLE
The dielectric constant ` ≈ 2 of the hydrocarbons of
a lipid bilayer is much less than that of water w ≈ 80.
Thus, the difference ∆Ew→` in the electrostatic energy
of an ion of charge q and effective radius a in the bilayer
and in water [27] is
∆Ew→` =
q2
8pi0a
(
1
`
− 1
w
)
(1)
or 3.5 eV if the ion’s charge is that of the proton and
its radius is a = 1 A˚. This energy barrier is far larger
than the 0.06 eV gained when a unit charge crosses a 60
mV phospholipid bilayer. Thus, an ion will not cross a
cell’s plasma membrane unless a transporter or a channel
facilitates (and regulates) its passage.
In the present model of CPP transduction, the electro-
statics of the CPP-cargo complex and the role of PSs on
the inner leaflet play key roles.
The electrostatics of a cationic polypeptide such as
TAT or polyarginine are more complex than for an ion.
I will model the CPP and its cargo in water as a sphere
with its positive charges on its surface. The density of a
protein of mass M kDa is estimated [28] to be
ρ(M) =
(
0.8491 + 0.0873 e−M/13
)
kDa/nm
3
. (2)
A CPP-cargo complex would not be expected to fold as
densely as a natural globular protein, and so for it the
estimate ρ(M) is more of an upper bound. The radius
r of a putative sphere consisting of M kDa of CPP and
cargo then would be at least
r &
(
3
4pi
M
ρ(M)
)1/3
nm. (3)
For instance, a CPP ofN arginines and a tiny fluorophore
cargo of 400 Da has a mass of MN = 0.1562N + 0.4 kDa,
and so its radius would satisfy
r &
(
3
4pi
MN
ρ(MN )
)1/3
nm (4)
which gives r = 0.75 nm for N = 8 arginines. The lower
bounds on the radii for N = 5–12 are listed in column 2
of the Table (I).
For larger cargos of Nc = 50–100 amino acids of 130
Da each, the lower bounds on the radii range from 1.25 to
1.59 nm. (In what follows, Nc will represent the number
of amino acids in the cargo or the mass of the cargo in
Daltons divided by 130 Da.) Adding another 0.8 nm for
the PC/SM head groups extends these lower bounds on
the radii to 2.05–2.39 nm. The diameters of these spheres
would approach or exceed the normal 4.4 nm of the lipid
bilayer. The extra energy penalty due to the distortion
of the plasma membrane may explain why CPPs can not
transduce cargos of more than 50 amino acids [16].
If the CPP-cargo molecule were a charged conducting
sphere of radius r and charge q, then its electrostatic
energy in water would be
E(N,Nc, q, w) =
q2
8pi0wr
. (5)
This term neglects the short-distance detail of the electric
field near the q/e positive unit charges e of the CPP-cargo
molecule. So a short-distance correction term
Esdc(N,Nc, q, w) =
qe
8pi0wa
(6)
proportional to q must be added to E(N,Nc, q, w). The
short distance a is an adjustable parameter, which should
turn out to be several A˚ since the term Esdc is a correc-
tion to be added to E(N,Nc, q, w) and not the entire
electrostatic energy.
As the CPP-cargo molecule enters the lipid bilayer,
the phosphate groups of the PC and SM of the outer
leaflet bind to the positively charged guanidinium and
amine groups of the CPP. The positive charges of the
phosphocholine groups of PC and SM are about d = 5 A˚
from their phosphate groups [29]. The binding of PC and
SM therefore approximately increases the effective radius
of the charged sphere to rm ≈ r + d. The electrostatic
energy of this complex in the hydrocarbon tails of the
lipid bilayer then is
E(N,Nc, q, `) ≈ q
2
8pi0`(r + d)
(7)
apart from a correction factor
Esdc(N,Nc, q, `) =
qe
8pi0`a
(8)
similar to (6).
Apart from correction terms, the electrostatic energy
penalty when the CPP-cargo molecule enters the lipid
bilayer from water as a CPP-cargo-PC/SM complex is
the difference
∆E0w,`(N,Nc, q) ≈ E(N,Nc, q, `)− E(N,Nc, q, w)(9)
≈ q
2
8pi0`(r + d)
(
1− r + d
r
`
w
)
.
Because the thickness t = 4.4 nm of the lipid bilayer is
only a few times that of the CPP-cargo-PC/SM complex,
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we also must include the Parsegian correction [27]
∆EP = − q
2
4pi0`t
ln
(
2w
w + `
)
. (10)
The sum of the water-to-lipid energy (9) and Parsegian’s
correction (10) is
∆Ew,`(N,Nc, q) = ∆E
0
w,`(N,Nc, q) + ∆EP . (11)
The energy ∆Ew,`(N,Nc, q) is listed in column 3 of Ta-
ble (I) for a CPP of N = 5–12 arginines towing a fluo-
rophore cargo of 400 Da with d = 0.5 nm.
The short-distance correction terms augment this
penalty by
∆Esdc(N,Nc, q) = Esdc(N,Nc, q, `)− Esdc(N,Nc, q, w)
=
qe
8pi0`a
(
1− `
w
)
(12)
and do not require Parsegian’s correction because they
are short-distance effects. This short-distance correction
∆Esdc is listed in column 4 of Table (I) for a CPP of N =
5–12 arginines and a representative value of a = 4.5 A˚
for the short-distance parameter.
The net electrostatic energy penalty when the CPP-
cargo molecule enters the lipid bilayer from water as a
CPP-cargo-PC/SM complex is then the sum of (9, 10, &
12)
∆Ew→` = ∆E0w,` + ∆EP + ∆Esdc. (13)
A CPP of 8 arginines carrying a fluorophore of 400 Da
has a radius r of 0.75 nm, and with a = 4.5 A˚, the change
(13) in its electrostatic energy on going from water to
lipid is
∆Ew→`(8, 3, 8e) ≈ 16.9 eV. (14)
This energy barrier is 35 times bigger than the energy
0.48 eV that it gains by crossing a potential difference of
60 mV. So how and why does it cross?
IV. A CPP–PS CAPACITOR AND
ELECTROPORATION
My answer lies in the second part of the present
model—the phosphatidylserines (PSs). They comprise
some 8–18% of the inner leaflet by weight [30]. The PSs
diffuse laterally within that leaflet with a diffusion con-
stant D ≈ 10−8 cm2/sec [31] and so within one second
spread to an area of 12 µm2, which is a significant frac-
tion of the surface area of a eukaryotic cell. Attracted
by the positive charge of two or more CPPs, several PSs
cluster in the inner leaflet below the CPPs forming with
them a kind of capacitor. In what follows, I will focus on
the PSs because they are constrained to lie in the two-
dimensional inner leaflet while other anions drift in the
TABLE I: The radius r of a CPP-cargo molecule of N
arginines and a cargo of 400 Da, its change in electrostatic
energy ∆Ew,` when transferred from water to hydrocarbon
(11), and the short-distance correction ∆ESDC (12). Dis-
tances are in nm and energies in electron-Volts.
N r ∆Ew,` ∆Esdc
5 0.67 4.61 3.90
6 0.70 6.39 4.68
7 0.73 8.41 5.46
8 0.75 10.64 6.24
9 0.78 13.06 7.02
10 0.80 15.68 7.80
11 0.82 18.48 8.58
12 0.84 21.44 9.36
three-dimensional cytosol.
After oligoarginine CPPs are added to the extra-
cellular fluid medium, the arginines of some of them will
bind to the phosphate groups of the phosphatidylcholine
(PC) and sphingomyelin (SM) phospholipids in the outer
leaflet. The electrostatic potential of an isolated CPP
may not be strong enough to form a pore because it is
reduced at a point r in the lipid by the mean relative
permittivity ¯ = (w + `)/2 to V (r) = q/(4pi0¯r) and
further reduced by counterions and image charges. But
if a second CPP or a few CPPs should land near the first
CPP and bind to PCs or SMs, then transduction becomes
possible in the present model.
A CPP of N arginines can form an α-helix of length
L ≈ 0.16N nm (or a β-strand of length 0.34N nm). If
two RN CPPs lie a distance d apart bound to phosphate
groups of the outer leaflet, then the charge 2Ne of the two
CPPs is spread over approximately Ld, giving a surface-
charge density of σ = 2N e/(dL). The electric field of
the two oligoarginines would attract 2N PSs to the part
of the inner leaflet below the two RN s forming a kind
of capacitor. If the voltage drop across this capacitor
exceeds the threshold for the formation of the pre-pores
or pores of electroporation, then the CPP and its cargo
may enter the cell. This threshold is between roughly
−250 and 550 mV, depending upon the duration of the
potential [32].
Due to its bidentate guanidinium group, arginine binds
to phosphate groups better than lysine [21, 33]. Thus,
oligoarginines would be more likely than oligolysines to
bind to the phospholipids of the outer leaflet forming
transiently stable capacitors with the PSs of the inner
leaflet.
CPPs with N = 12 arginines can bind to more than
one phosphate group, and so they can bind to more than
one phospholipid of the outer leaflet. The number of
such binding sites drops with the number of Rs. In the
“picket-fence model,” transmembrane proteins bind to
actin and restrict the motion of outer-leaflet proteins and
lipids [34]; so I assume that oligoarginines with N > 8
remain approximately stable for a few hundred ms.
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To include the effects of entropy and of the geometry
of the oligoarginines (RN s) and the phosphatidylserines
(PSs), I wrote and ran a Monte Carlo program (included
as supplementary material). In this code, I assumed that
two RN s were parallel α-helices a distance d apart bound
to phosphate groups of the outer leaflet. The PSs were
allowed to move in two dimensions in the inner leaflet at
sites rk for k = 1, . . . 2N . The 2N positive charges of the
two RN s are taken to lie fixed at the points
r±j CPP = (± d/2, 0.16 (N/2− j), t) (15)
in which the ±-signs label the two RN s, and j labels the
Rs of the RN s ( 0 ≤ j ≤ N). The electrostatic energy of
the PSs then is approximately
E =
1
4pi0¯
NPS∑
i=2
i−1∑
k=1
e2
|ri − rk| −
NPS∑
k=1
N∑
j=1
qe
|ri − r±j CPP |

(16)
in which ¯ is the mean permittivity
¯ =
1
2
(w + `) . (17)
The Monte Carlo code used a simple Metropolis step in
which the x-y coordinates of all the PSs were randomly
varied, each by less than ±0.025 nm. The code accepted
any change in the positions of the PSs that lowered their
energy E as given by (16) and accepted any change that
raised their energy by ∆E conditionally with probability
P = e−∆E/(kT ) (18)
in which k is Boltzmann’s constant and T is 37 Celsius.
The simulation took place in a two-dimensional box with
side L =
√
N/0.13 nm, and periodic boundary conditions
were enforced to keep the number density of PSs constant
at 13% within the box.
Each simulation started from a random configuration
of PSs on the inner leaflet and ran for at least 10 mil-
lion Metropolis steps. After at least 2 million steps for
thermalization, measurements of the positions of the PSs
and of the electrostatic potential were taken every 1000
steps, and the positions of the PSs were recorded every
80,000 steps. The distnace d separating the two CPPs
was taken to be d = 2, 3, and 4 nm. (The simulations
for d = 3 used ten times as many steps.)
The voltages were measured at the points (0, 0, t) and
(0, 0,−0.1) nm. The offset by 0.1 nm was to avoid the
chance arrival of a PS at the point (0, 0, 0). The voltage
differences ∆V = V (0, 0,−0.1) − V (0, 0, t) are displayed
in the Table II. At all three separations, CPPs with 9
or more Rs produce voltages that exceed the threshold
( ∼ 250–∼ 550 mV ) for the formation of pre-pores or
pores [32]. CPPs with 10 or more Rs may exceed the
threshold for irreversible electroporation.
The mean value of the distance of the PSs from the
TABLE II: The voltage differences ∆V (mV) across the
plasma membrane due to two RN oligoarginines on the outer
leaflet separated by a distance d nm and a flock of 2N phos-
phatidylserines fluttering below them on the inner leaflet.
N ∆V d = 2 nm ∆V d = 3 nm ∆V d = 4 nm
5 −342 −229 −173
6 −398 −266 −198
7 −449 −300 −223
8 −504 −335 −248
9 −553 −369 −273
10 −601 −401 −297
11 −646 −433 −319
12 −687 −465 −340
point (0, 0, 0) varied between 〈r〉 = 11.8 nm for two R5s
separated by 2 nm and 〈r〉 = 27.5 nm for two R12s sepa-
rated by 4 nm.
In the present model, a CPP-PS capacitor increases the
membrane potential sufficiently to cross the threshold for
electroporation, at least for RN s with enough arginines.
In its use of an electric field and of the binding of the
CPPs to the phosphate groups of the phospholipids of the
outer leaflet, the model has something in common with
the adaptive-translocation model of Rothbard, Jessop,
and Wender [21]; in its use of neutral dipolar PC & SM
head groups it is somewhat similar to the work of Herce
and Garcia [35] and of Tang, Waring, and Hong [36]. The
key distinctive feature of the present model is the role of
PSs in forming with the CPPs a CPP-PS capacitor with
a voltage high enough to cause electropration.
V. COMPARISON WITH EXPERIMENT
Tu¨nnemann et al. [23] measured the ability of the L-
and D-isoforms of oligolysine and of oligoarginine to carry
fluorophores of ∼400 Da into live cells. They found that
oligoarginines transduced the fluorophores much better
than oligolysines, that more arginines meant faster trans-
duction, with L-R9 and L-R10 doing better than their
shorter counterparts, and that the D-isoforms worked
better than the L-isoforms, probably because of their
greater resistance to proteases.
The present model is consistent with these experimen-
tal facts and explains them as follows: The oligoarginines
crossed cell membranes more easily than the oligolysines
because they were better able to bind to the phosphate
groups of the PCs and SMs in the outer leaflet; the
oligolysines were not able to form a stable upper plate of
the CPP-PS capacitor. CPPs with more arginines were
transduced more rapidly because with more arginines
they could bind to more PCs and SMs and because their
higher charge led to a higher trans-membrane potential.
The D-isoforms worked better than the L-isoforms be-
cause the capacitor mechanism is insensitive to the chi-
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rality of the amino acids and because proteases were less
able to cut them.
This consistency of the capacitor model lends it some
plausibility. The simplicity of the model suggests that it
may apply to other oligocationic CPPs. But evolution
finds what works, not what fits neatly into a model, and
so other CPPs with different cargos may enter different
cells by different mechanisms.
VI. HOW TO TEST THIS MODEL
One way to test the model would be to compare the
rates of polyarginine transduction in wild-type cells and
in those that have little or no phosphatidylserine (PS) in
their plasma membranes. If PS plays a key role as in the
model of this paper, then the transduction of polyargi-
nine fused to a cargo of less than 30 amino acids should
be faster in the wild-type cells than in those without PS
in their plasma membranes. Mammalian cell lines that
are deficient in the synthesis of phosphatidylserine do ex-
ist [37–41], but they appear to have normal levels of PS
in their plasma membranes [41]—presumably due to a
lower rate of PS degradation [42].
Another test would be to construct artificial asymmet-
ric bilayers [43–45] with and without PS on the “cytoso-
lic” side and to compare the rates of CPP-cargo trans-
duction. If the present model is right, then the rate of
transduction should be higher through membranes with
PS on the cytosolic side than through membranes with
no PS or with PS on both sides.
If CPPs do enter cells via molecular electroporation,
then it may be possible to observe the formation of the
transient pores by detecting changes in the conductance
of the membrane [32]. Such measurements would be a
third test of the model and would let one determine both
whether CPP-transduction is related to the presence of
PS on the cytosolic side of the membrane and whether it
proceeds via molecular electroporation.
VII. SUMMARY
Cell-penetrating peptides can carry into cells cargos
with molecular weights of an order of magnitude greater
than the nominal limit 500 of the “rule of 5” [46]. Sec-
tion IV describes a model in which phosphatidylserines
(PSs) play key roles in the transduction of CPP-cargo
molecules. In this model, the positively charged CPP
on the outer leaflet and the negatively charged PSs on
the inner leaflet form a kind of capacitor with a trans-
membrane potential sufficient for electroporation (-250
to -550 mV). The model is consistent with experimental
data [23] on the transduction of the L- and D-isomers of
oligoarginine and oligolysine CPPs into mouse myoblasts.
The model predicts that mammalian cells that lack
phosphatidylserine in their plasma membranes transduce
oligocations poorly, that artificial asymmetric bilayers
with PS on the cytosolic side transduce oligocations bet-
ter than ones without PS, and that transduction is ac-
companied by brief changes in the conductance of the
membrane.
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